<DOC>
	<DOCNO>NCT02134769</DOCNO>
	<brief_summary>Bionecteur® protective non-touch applicator ensure aseptic connection make Vygon . However , study describe positive effect use Bionecteurs ® regard catheter-related bloodstream infection . In study Bionecteur® use central venous line arterial line postoperative patient 40-bed ICU . The incidence catheter-related bloodstream infection compare patient without inclusion Bionecteur® device .</brief_summary>
	<brief_title>Influence Bionecteurs Catheter-associated Infection</brief_title>
	<detailed_description>- Prospective , randomise observational study - Postsurgical patient anesthesiological ICU ICU LOS ( LOS : length stay ) &gt; 3 day - Inclusion : -- -- Age ≥ 18 year -- - . demand central venous arterial line -- - write consent patient and/or assignee - Exclusion - Handicapped patient - patient ICU LOS &lt; 3 day - Study design 1 . Three day admission ICU blood culture draw exclude preexist blood stream infection 2 . Patients bed even number assign Bionecteur® group . Control group ( without use bionecteurs ) patient odd bed number . 3 . Biconecteurs® connect lumens central catheter arterial catheter . Control group treat without use Bionecteurs® . Handling vascular catheter perform described institutional guideline group . 4 . Catheter-related bloodstream infection monitor independent person ICU treatment 5 . The study finish ab discharge ICU removal catheter .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>Length Stay ( LOS ) ICU &gt; 3 day write consent patient notarial carers medical indication central venous line/arterial line handicap LOS ICU &lt; 3 day consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>catheter-related bloodstream infection</keyword>
</DOC>